跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
赛机宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Cisatracurium Besylate Injection
Approved
化学药品
Cisatracurium Besylate Injection
Aspen Pharmacare Australia Pty Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Jun 11, 2021
Approval ID
8DqlgaNZdWY
Company
Aspen Pharmacare Australia Pty Ltd.
Type
化学药品
Approval Details
Approval Id
8DqlgaNZdWY
Approval Number
国药准字HJ20181157
Generic Name
苯磺顺阿曲库铵注射液
Generic Name En
Cisatracurium Besylate Injection
Trade Name
赛机宁
Drug Type
化学药品
Dosage Form
注射剂
Strength
2.5ml:5mg
Reg Date
2021-06-11
Expired Date
2026-06-10
Company Name
Aspen Pharmacare Australia Pty Ltd.
Production Company Name
GLAXOSMITHKLINE MANUFACTURING SPA
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Production Company Detail Path
/organization/glaxosmithkline-manufacturing-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 11, 2021
Approval ID
8DqlgaNZdWY
Type
化学药品
Back to NMPA Approvals